Muzaffar Qazilbash, M.D., is a nonresident scholar for biomedical research policy in the Center for Health and Biosciences. He serves as professor of medicine and director of myeloma transplantation and cellular therapy in the Department of Stem Cell Transplantation at The University of Texas MD Anderson Cancer Center.
Qazilbash’s research focuses on the development of novel therapies for stem cell transplantation and immunotherapy for patients with multiple myeloma, a common blood cancer. He has successfully taken cancer vaccines from basic science laboratories to clinical trials for patients with blood cancers. His research also focuses on improving the safety and effectiveness of stem cell transplants for patients with blood cancers. Qazilbash has authored or co-authored more than 175 peer-reviewed articles in medical journals, is a member of several professional societies, and takes keen interest in health policy and its impact on biomedical research. He is also a practicing hematologist at the MD Anderson Cancer Center.
Qazilbash obtained his medical degree from the University of Karachi, Pakistan. He was trained in internal medicine at the University of Connecticut and in hematology and oncology at the National Institutes of Health in Bethesda, Maryland.